India Grants a Compulsory Licence of Bayer’s Patented Cancer Drug: The Issue of Local Working Requirement
post by Enrico Bonadio
The report analyses the first compulsory licence granted by the Indian government.
The author argues that the decision adopted by India might be in violation of the non discrimination principle enshrined in Article 27(1) TRIPS Agreement
For the full report see here.